ComparisiOn of Neointimal coVerage betwEen zotaRolimus Eluting Stent and Everolimus Eluting Stent Using Optical Coherence Tomography at 3 Months

Trial Profile

ComparisiOn of Neointimal coVerage betwEen zotaRolimus Eluting Stent and Everolimus Eluting Stent Using Optical Coherence Tomography at 3 Months

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2012

At a glance

  • Drugs Everolimus; Zotarolimus
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis
  • Focus Pharmacodynamics
  • Acronyms COVER-OCT-II
  • Most Recent Events

    • 13 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top